Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of RNA- market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of RNA-market, defines the market attractiveness level of RNA- market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of RNA- industry, describes the types of RNA- market, the applications of major players and the market size, and deeply analyzes the current situation of the global RNA- market and the development prospects and opportunities of RNA- industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global RNA- market in Chapter 13.
By Player:
Gradalis
Arrowhead Pharmaceuticals
Alnylam Pharmaceuticals
Quark
Roche
Sanofi-Aventis
Benitec Biopharma
Silence Therapeutics
Abbott Laboratories
Silenseed
Senesco
RXi
Dicerna
Calimmune Inc
Tekmira
Pfizer
By Type:
Type 1
Type 2
Type 3
By End-User:
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 RNA- Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 RNA- Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 RNA- Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 RNA- Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise RNA- Market Analysis and Outlook to 2022
-
7.1 Global RNA- Consumption (2017-2022)
-
7.2 United States RNA- Consumption (2017-2022)
-
7.3 Europe RNA- Consumption (2017-2022)
-
7.4 China RNA- Consumption (2017-2022)
-
7.5 Japan RNA- Consumption (2017-2022)
-
7.6 India RNA- Consumption (2017-2022)
-
7.7 South Korea RNA- Consumption (2017-2022)
8 Region and Country-wise RNA- Market Analysis and Outlook to 2028
-
8.1 Global RNA- Consumption Forecast (2022-2028)
-
8.2 United States RNA- Consumption Forecast (2022-2028)
-
8.3 Europe RNA- Consumption Forecast (2022-2028)
-
8.4 China RNA- Consumption Forecast (2022-2028)
-
8.5 Japan RNA- Consumption Forecast (2022-2028)
-
8.6 India RNA- Consumption Forecast (2022-2028)
-
8.7 South Korea RNA- Consumption Forecast (2022-2028)
9 Global RNA- Market Outlook by Types and Applications to 2022
-
9.1 Global RNA- Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Type 3 Consumption and Growth Rate (2017-2022)
-
9.2 Global RNA- Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Tuberculosis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global RNA- Market Outlook by Types and Applications to 2028
-
10.1 Global RNA- Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global RNA- Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global RNA- Import and Export Analysis (Top 5 Countries)
-
11.1 Global RNA- Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global RNA- Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 RNA- Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global RNA- Market Competitive Analysis
-
14.1 Gradalis
-
14.1.1 Gradalis Company Details
-
14.1.2 Gradalis RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gradalis RNA- Product and Service
-
14.2 Arrowhead Pharmaceuticals
-
14.2.1 Arrowhead Pharmaceuticals Company Details
-
14.2.2 Arrowhead Pharmaceuticals RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Arrowhead Pharmaceuticals RNA- Product and Service
-
14.3 Alnylam Pharmaceuticals
-
14.3.1 Alnylam Pharmaceuticals Company Details
-
14.3.2 Alnylam Pharmaceuticals RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Alnylam Pharmaceuticals RNA- Product and Service
-
14.4 Quark
-
14.4.1 Quark Company Details
-
14.4.2 Quark RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Quark RNA- Product and Service
-
14.5 Roche
-
14.5.1 Roche Company Details
-
14.5.2 Roche RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche RNA- Product and Service
-
14.6 Sanofi-Aventis
-
14.6.1 Sanofi-Aventis Company Details
-
14.6.2 Sanofi-Aventis RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sanofi-Aventis RNA- Product and Service
-
14.7 Benitec Biopharma
-
14.7.1 Benitec Biopharma Company Details
-
14.7.2 Benitec Biopharma RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Benitec Biopharma RNA- Product and Service
-
14.8 Silence Therapeutics
-
14.8.1 Silence Therapeutics Company Details
-
14.8.2 Silence Therapeutics RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Silence Therapeutics RNA- Product and Service
-
14.9 Abbott Laboratories
-
14.9.1 Abbott Laboratories Company Details
-
14.9.2 Abbott Laboratories RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Abbott Laboratories RNA- Product and Service
-
14.10 Silenseed
-
14.10.1 Silenseed Company Details
-
14.10.2 Silenseed RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Silenseed RNA- Product and Service
-
14.11 Senesco
-
14.11.1 Senesco Company Details
-
14.11.2 Senesco RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Senesco RNA- Product and Service
-
14.12 RXi
-
14.12.1 RXi Company Details
-
14.12.2 RXi RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 RXi RNA- Product and Service
-
14.13 Dicerna
-
14.13.1 Dicerna Company Details
-
14.13.2 Dicerna RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Dicerna RNA- Product and Service
-
14.14 Calimmune Inc
-
14.14.1 Calimmune Inc Company Details
-
14.14.2 Calimmune Inc RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Calimmune Inc RNA- Product and Service
-
14.15 Tekmira
-
14.15.1 Tekmira Company Details
-
14.15.2 Tekmira RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Tekmira RNA- Product and Service
-
14.16 Pfizer
-
14.16.1 Pfizer Company Details
-
14.16.2 Pfizer RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Pfizer RNA- Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of RNA-
-
Figure RNA- Picture
-
Table Global RNA- Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNA- Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNA- Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global RNA- Consumption by Country (2017-2022)
-
Figure United States RNA- Consumption and Growth Rate (2017-2022)
-
Table Europe RNA- Consumption and Growth Rate (2017-2022)
-
Figure China RNA- Consumption and Growth Rate (2017-2022)
-
Figure Japan RNA- Consumption and Growth Rate (2017-2022)
-
Figure India RNA- Consumption and Growth Rate (2017-2022)
-
Figure South Korea RNA- Consumption and Growth Rate (2017-2022)
-
Figure Global RNA- Consumption Forecast by Country (2022-2028)
-
Figure United States RNA- Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe RNA- Consumption Forecast and Growth Rate (2022-2028)
-
Figure China RNA- Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan RNA- Consumption Forecast and Growth Rate (2022-2028)
-
Figure India RNA- Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea RNA- Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Tuberculosis Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global RNA- Import by Region (Top 5 Countries) (2017-2028)
-
Table Global RNA- Export by Region (Top 5 Countries) (2017-2028)
-
Table Gradalis (Foundation Year, Company Profile and etc.)
-
Table Gradalis RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gradalis RNA- Product and Service
-
Table Arrowhead Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Arrowhead Pharmaceuticals RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arrowhead Pharmaceuticals RNA- Product and Service
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals RNA- Product and Service
-
Table Quark (Foundation Year, Company Profile and etc.)
-
Table Quark RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quark RNA- Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche RNA- Product and Service
-
Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis RNA- Product and Service
-
Table Benitec Biopharma (Foundation Year, Company Profile and etc.)
-
Table Benitec Biopharma RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Benitec Biopharma RNA- Product and Service
-
Table Silence Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Silence Therapeutics RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Silence Therapeutics RNA- Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories RNA- Product and Service
-
Table Silenseed (Foundation Year, Company Profile and etc.)
-
Table Silenseed RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Silenseed RNA- Product and Service
-
Table Senesco (Foundation Year, Company Profile and etc.)
-
Table Senesco RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Senesco RNA- Product and Service
-
Table RXi (Foundation Year, Company Profile and etc.)
-
Table RXi RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table RXi RNA- Product and Service
-
Table Dicerna (Foundation Year, Company Profile and etc.)
-
Table Dicerna RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dicerna RNA- Product and Service
-
Table Calimmune Inc (Foundation Year, Company Profile and etc.)
-
Table Calimmune Inc RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Calimmune Inc RNA- Product and Service
-
Table Tekmira (Foundation Year, Company Profile and etc.)
-
Table Tekmira RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tekmira RNA- Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer RNA- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer RNA- Product and Service
-
